Moderna
MRNA
#1409
Rank
HK$98.82 B
Marketcap
HK$256.80
Share price
3.35%
Change (1 day)
-63.97%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -HK$71.67

According to Moderna 's latest financial reports the company's current EPS (TTM) is -HK$71.15. In 2022 the company made an earnings per share (EPS) of HK$164.40 a decrease over its 2021 EPS that were of HK$235.71.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$71.67-143.59%
2022HK$164.40-30.25%
2021HK$235.71-1660.82%
2020-HK$15.1025.16%
2019-HK$12.0737.04%
2018-HK$8.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$13.16-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.18-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$23.59-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$31.99-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.11-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$13.23-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.64-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA